Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 103

1.

Changes of energy metabolism, nutritional status and serum cytokine levels in patients with Crohn's disease after anti-tumor necrosis factor-α therapy.

Nishida N, Sasaki M, Kurihara M, Ichimaru S, Wakita M, Bamba S, Andoh A, Fujiyama Y, Amagai T.

J Clin Biochem Nutr. 2013 Sep;53(2):122-7. doi: 10.3164/jcbn.13-18. Epub 2013 Aug 31.

PMID:
24062610
[PubMed]
Free PMC Article
2.

Resting energy expenditure before and after surgical resection of gut lesions in pediatric Crohn's disease.

Varille V, Cézard JP, de Lagausie P, Bellaiche M, Tounian P, Besnard M, Faure C, Aigrain Y, Girardet JP, Navarro J.

J Pediatr Gastroenterol Nutr. 1996 Jul;23(1):13-9.

PMID:
8811517
[PubMed - indexed for MEDLINE]
3.

Positive impact of blocking tumor necrosis factor alpha on the nutritional status in pediatric Crohn's disease patients.

Diamanti A, Basso MS, Gambarara M, Papadatou B, Bracci F, Noto C, Castro M.

Int J Colorectal Dis. 2009 Jan;24(1):19-25. doi: 10.1007/s00384-008-0578-x. Epub 2008 Sep 17.

PMID:
18797887
[PubMed - indexed for MEDLINE]
4.

Impact of Disease Activity on Resting Energy Expenditure and Body Composition in Adult Crohn's Disease: A Prospective Longitudinal Assessment.

Gong J, Zuo L, Guo Z, Zhang L, Li Y, Gu L, Zhao J, Cao L, Zhu W, Li N, Li J.

JPEN J Parenter Enteral Nutr. 2014 Mar 25. [Epub ahead of print]

PMID:
24668997
[PubMed - as supplied by publisher]
5.

Measurement of nutrition status in Crohn's disease patients receiving infliximab therapy.

Wiese D, Lashner B, Seidner D.

Nutr Clin Pract. 2008 Oct-Nov;23(5):551-6. doi: 10.1177/0884533608323421.

PMID:
18849561
[PubMed - indexed for MEDLINE]
6.

A systematic review and economic evaluation of the use of tumour necrosis factor-alpha (TNF-α) inhibitors, adalimumab and infliximab, for Crohn's disease.

Dretzke J, Edlin R, Round J, Connock M, Hulme C, Czeczot J, Fry-Smith A, McCabe C, Meads C.

Health Technol Assess. 2011 Feb;15(6):1-244. doi: 10.3310/hta15060. Review.

PMID:
21291629
[PubMed - indexed for MEDLINE]
Free Article
7.

Estimated versus measured basal energy requirements in patients with Crohn's disease.

Chan AT, Fleming CR, O'Fallon WM, Huizenga KA.

Gastroenterology. 1986 Jul;91(1):75-8.

PMID:
3710083
[PubMed - indexed for MEDLINE]
8.

High serum tumor necrosis factor-alpha levels are associated with lack of response to infliximab in fistulizing Crohn's disease.

Martínez-Borra J, López-Larrea C, González S, Fuentes D, Dieguez A, Deschamps EM, Pérez-Pariente JM, López-Vázquez A, de Francisco R, Rodrigo L.

Am J Gastroenterol. 2002 Sep;97(9):2350-6.

PMID:
12358255
[PubMed - indexed for MEDLINE]
9.

Blockade of tumour necrosis factor-alpha in rheumatoid arthritis: effects on components of rheumatoid cachexia.

Metsios GS, Stavropoulos-Kalinoglou A, Douglas KM, Koutedakis Y, Nevill AM, Panoulas VF, Kita M, Kitas GD.

Rheumatology (Oxford). 2007 Dec;46(12):1824-7.

PMID:
18032540
[PubMed - indexed for MEDLINE]
Free Article
10.

Protein and energy metabolism response to the initial dose of infliximab in children with Crohn's disease.

Steiner SJ, Pfefferkorn MD, Fitzgerald JF, Denne SC.

Inflamm Bowel Dis. 2007 Jun;13(6):737-44.

PMID:
17243138
[PubMed - indexed for MEDLINE]
11.

Tumor necrosis factor-alpha antibody for maintenance of remission in Crohn's disease.

Behm BW, Bickston SJ.

Cochrane Database Syst Rev. 2008 Jan 23;(1):CD006893. doi: 10.1002/14651858.CD006893. Review.

PMID:
18254120
[PubMed - indexed for MEDLINE]
12.

Energy metabolism in Japanese patients with Crohn's disease.

Sasaki M, Johtatsu T, Kurihara M, Iwakawa H, Tanaka T, Tsujikawa T, Fujiyama Y, Andoh A.

J Clin Biochem Nutr. 2010 Jan;46(1):68-72. doi: 10.3164/jcbn.09-55. Epub 2009 Dec 29.

PMID:
20104267
[PubMed]
Free PMC Article
13.

Energy expenditure and body composition in children with Crohn's disease: effect of enteral nutrition and treatment with prednisolone.

Azcue M, Rashid M, Griffiths A, Pencharz PB.

Gut. 1997 Aug;41(2):203-8.

PMID:
9301499
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

The role of oxidative stress in anti-tumor necrosis factor antibody treatment in Crohn's disease.

Kupčova V, Tureckỳ L, Uhlíkova E.

Curr Med Chem. 2012;19(30):5226-31.

PMID:
23061628
[PubMed - indexed for MEDLINE]
15.

Cytokine network in chronic perianal Crohn's disease and indeterminate colitis after colectomy.

Ruffolo C, Scarpa M, Faggian D, Romanato G, De Pellegrin A, Filosa T, Prando D, Polese L, Scopelliti M, Pilon F, Ossi E, Frego M, D'Amico DF, Angriman I.

J Gastrointest Surg. 2007 Jan;11(1):16-21.

PMID:
17390181
[PubMed - indexed for MEDLINE]
16.

Impact of disease activity on resting energy expenditure in children with inflammatory bowel disease.

Wiskin AE, Wootton SA, Culliford DJ, Afzal NA, Jackson AA, Beattie RM.

Clin Nutr. 2009 Dec;28(6):652-6. doi: 10.1016/j.clnu.2009.05.007. Epub 2009 Jun 9.

PMID:
19515463
[PubMed - indexed for MEDLINE]
17.

A high serum concentration of interleukin-6 is predictive of relapse in quiescent Crohn's disease.

Louis E, Belaiche J, van Kemseke C, Franchimont D, de Groote D, Gueenen V, Mary JY.

Eur J Gastroenterol Hepatol. 1997 Oct;9(10):939-44.

PMID:
9391781
[PubMed - indexed for MEDLINE]
18.

Correlations between skin lesions induced by anti-tumor necrosis factor-α and selected cytokines in Crohn's disease patients.

Włodarczyk M, Sobolewska A, Wójcik B, Loga K, Fichna J, Wiśniewska-Jarosińska M.

World J Gastroenterol. 2014 Jun 14;20(22):7019-26. doi: 10.3748/wjg.v20.i22.7019.

PMID:
24944497
[PubMed - in process]
Free PMC Article
19.

[Effectiveness of anti-TNF alpha antibodies in treatment of fistulizing Crohn's disease].

Rozpondek P, Zwolińska-Wcisło M, Przybylska M, Mach T.

Przegl Lek. 2011;68(9):602-5. Polish.

PMID:
22335009
[PubMed - indexed for MEDLINE]
20.

Management of inflammatory bowel disease with infliximab and other anti-tumor necrosis factor alpha therapies.

Magro F, Portela F.

BioDrugs. 2010 Dec 14;24 Suppl 1:3-14. doi: 10.2165/11586290-000000000-00000. Review.

PMID:
21175228
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk